MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyer, J. L.
Right arrow Articles by Harden, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyer, J. L.
Right arrow Articles by Harden, T. K.

Irreversible activation of phospholipase C-coupled P2Y-purinergic receptors by 3'-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate

JL Boyer and TK Harden

Department of Pharmacology, University of North Carolina, School of Medicine, Chapel Hill 27599.

3'-O-(4-Benzoyl)benzoyladenosine 5'-triphosphate (BzATP), a photoaffinity analog of ATP, was used as a ligand for the phospholipase C-linked P2Y-purinergic receptor in turkey erythrocytes. In membranes from [3H]inositol-labeled turkey erythrocytes, BzATP stimulated inositol phosphate formation in a concentration-dependent manner (K0.5 = 172 +/- 4 nM). The effect of BzATP was strictly dependent on the presence of guanine nucleotides and was not additive with the effect of other full P2Y-purinergic receptor agonists. Photolysis of [3H]- inositol-labeled membranes in the presence of BzATP had no effect on the magnitude of the maximally attainable response of phospholipase C to the P2Y-purinergic receptor agonist adenosine 5'-O-(2- thiodiphosphate) (ADP beta S) plus guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S). However, the effects of submaximally effective concentrations of GTP gamma S were markedly increased in membranes previously photolyzed in the presence of BzATP. In addition, the rate of activation of phospholipase C by GTP gamma S in membranes photolyzed in the presence of BzATP was increased 3-fold, as compared with control membranes. BzATP effects on phospholipase C were prevented by photolysis in the presence of ATP or ADP, but not by the presence of the weak P2Y-purinergic receptor agonist beta,gamma-methyleneadenosine 5'-triphosphate. These results suggest that BzATP is a full P2Y- purinergic receptor agonist, which after photolysis becomes irreversibly associated with turkey erythrocyte membranes and promotes P2Y-purinergic receptor-mediated guanine nucleotide-dependent activation of phospholipase C.

Volume 36, Issue 6, pp. 831-835, 12/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics